@LAB_150
 Toronto, Ontario
lab150.com
Joined December 2017
  • Tweets217
  • Following91
  • Followers86
5Media
Thank you for visiting LAB150. LAB150 is one of TIAP's core programs, and we encourage you to follow us at one or all of: tiap.ca @TIAPToronto or find us on LinkedIn under Toronto Innovation Acceleration Partners / TIAP
25
Calling all Analysts! We are hiring! We need an Analyst for our LifeSciences team to support expansion of our LAB150 program, & company creation diligence. Check out the job posting & share with anyone you think might be a good fit! tiap.applytojobs.ca/life sciences/17721 #hiring
1
2
TIAP portfolio co @Zucara_ca is moving their lead program targeting diabetes into Phase II clinical trials. Congratulations to the team and great progress for patients and their families worldwide. Read more here: zucara.ca/news/zucara-therap…
1
3
Thank you @wencyleung for your interest in our research.
Krembil Brain Institute@KBI_UHN21 Jun 2022
"What if #Alzheimer’s is an #autoimmune disease? Toronto neurologist awarded for work on unconventional hypothesis." Thank you @wencyleung @globeandmail for this fascinating story on @DrDonWeaver's pioneering research ⇨ tgam.ca/3zQRs7h
3
17
More good news from TIAP portfolio company @Zucara_ca. Positive Phase 1B data provides great promise for preventing hypoglycaemia in diabetic patients. TIAP founded & invested in Zucara based on innovation from @UofT: prn.to/3Ow4GKO #diabetes #lifesciences #TIAPportfolio
1
5
We're celebrating all the incredible women in Ontario's #clinicaltrials community today! 👏Follow this thread to read about some of the work being done by women in our province. #IWD2022 #onhealth
1
2
4
TIAP portoflio company @Zucara_ca awaiting proof-of-concept data to prevent insulin-induced hypoglycemia in people with diabetes biotuesdays.com/2022/02/01/z… #diabetes #TIAPportfolio @UofT @FedDevOntario

Zucara awaiting proof-of-concept data to prevent insulin-induced hypoglycemia in people with...

Closely held Zucara Therapeutics expects to release results in the second quarter of its Phase 1b proof-of-concept study with its once-daily drug candidate, ZT-01, to prevent insulin-induced hypogl...

biotuesdays.com
1
4
Congrats to @Vasomune on new Phase 2a clinical trial! This portfolio co. was supported through our targeted management programs. Collab with our member @Sunnybrook advanced its novel therapeutic strategy to this exciting stage. #lifesciences #TIAPportfolio #covid @FedDevOntario
Latest News from Business Wire@NewsFromBW18 Jan 2022
Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease dlvr.it/SHLF6h
1
4
UTEST lands in the Top Ten of the Narwhal Project's recent ranking for Best Canadian Accelerators and Incubators. Rankings are based on capital raised post accelerator involvement, i.e. the venture's ability to scale after graduation. UTEST's portfolio: utest.to/entrepreneurs/

University of Toronto Early Stage Technology (UTEST)

University of Toronto Early Stage Technology (UTEST) Program provides support to the University of Toronto’s emerging deep tech entrepreneurs.

utest.to
BetaKit
@BetaKit13 Dec 2021
Well known for its annual list highlighting Canada’s fastest-growing tech companies, The Narwhal Project has created a new index ranking Canada’s accelerators. #CDNtech betakit.com/narwhal-project-…

Canadian accelerator ranking shows need for improvement compared to US

Well known for its annual list highlighting Canada’s fastest-growing tech companies, The Narwhal Project has created a new index ranking Canada’s accelerators.

betakit.com
6
1
11
Check out these exiting opportunities at UHN for commercialization professionals! #commercialization #innovationjobs
This Post is from an account that no longer exists. Learn more
1
A super useful webinar for startups - bring questions, get answers! #incorporation #fundraising #startup
UTEST, University of Toronto@UTESTto20 Oct 2021
You're a #UofTStartup founder with lots of questions around the process of incorporating and raising funds - ask the professionals! 👇 Thursday, Oct 28, 1:00PM EST Register here: eventbrite.com/e/uoft-startu…
2
4
This should be top of the agenda for all parties - and voters. As if the pandemic wasn't reminder enough of the importance of innovation, in life sciences and indeed all areas! @FedDevOntario #lifescienceinnovation #innovationeconomy
Sean Silcoff@SeanSilcoff7 Sep 2021
I read through the platforms of the three main federal parties in search of their innovation strategies for Canada. What I found hasn't exactly thrilled experts who were hoping for policies to help create meaningful economic prosperity/via @globeandmail theglobeandmail.com/business…

Conservatives aim to wrest innovation leadership from Liberals - but critics say neither party...

Innovation commentators have long complained about a lack of sophistication and strategic thinking in Ottawa, as the Conservatives try to take the lead with an innovation platform

theglobeandmail.com
1
1
Very interesting article on amazing scientific sleuthing, and shows the absolute need & reason for strong investment in life sciences. Thanks for sharing, @OICR! @FedDevOntario @melaniejoly #TIAPportfolio
Ontario Institute for Cancer Research (OICR)@OICR_news3 Sep 2021
Via @SmithsonianMag - A Marine Bacteria Species Shows Promise for Curing an Aggressive Brain Cancer ow.ly/15It50G3WxH This treatment was developed with the support of Triphase Accelerator Corp., which was co-founded by OICR and @TIAPToronto.

A Marine Bacteria Species Shows Promise for Curing an Aggressive Brain Cancer

A new glioblastoma drug is derived from a microbe found in the ocean at depths of up to 6,500 feet

smithsonianmag.com
1
4
Amazing! #TIAPportfolio
TIAP - Toronto Innovation Acceleration Partners@TIAPToronto28 Jul 2021
Fabulous! Congrats to UTEST alumni @deepgenomics for attracting important international & domestic investors. The underlying academic research comes from our Member, University of Toronto @researchuoft @FedDevOntario @melaniejoly @hassanjaferi #TIAPportfolio
We are excited to start our proof-of-concept trial of ZT-01 dosed prior to a hypoglycemia challenge in people with T1D. This Phase 1b trial builds on our recent study that showed ZT-01 was safe and well tolerated. zucara.ca/news/zucara-therap…
2
3
Congrats to our portfolio co @Zucara_ca for initiating its Phase 1b trial. Great to see continuing advances in diabetes being developed by TIAP member @UofT right here in Ontario! bit.ly/3l2jwgn @FedDevOntario @TIAPportfolio #diabetes
1
3
Wonderful news. Congratulations to UHN and the Adela team!
Brad Wouters 🇨🇦@bradwouters23 Jun 2021
Exciting news for Adela, our latest @uhn @pmcancercentre startup - working to bring discovery to impact. globe2go.pressreader.com/art…

Toronto biotech startup Adela raises $60-mil­lion from top U.S. in­vestors | The Globe and Mail...

Com­pany aims to iden­tify mul­ti­ple types of can­cers and other con­di­tions with a sim­ple blood test A lead­ing biotech­nol­ogy startup from Toronto’s Univer­sity Health Net­work (UHN) has raised...

globe2go.pressreader.com
1
8
We are hiring! We are looking for an Analyst, Technology & Venture Development, to work closely with our life sciences team, principal investigators & research community as well as our Members. For more info: tiap.humi.ca/job-board/staff… #TIAPjobs #TIAPhiring #Careers #lifesciencejob
1
1
5
UTEST's 2021 program applications are now open! In partnership with @TIAPToronto , we provide #UofT early-stage companies with mentorship, legal expertise, capital and access to networks. #innovation utest.to/ Applications due by 11:59PM on June 3rd, 2021
4
5
A spotlight on the pressing issue of talent in Canadian biotech @FedDevOntario @melaniejoly @FP_Champagne
Jim Wilson 🇨🇦@OfficeOccupier26 Apr 2021
The Canadian #biotech #lifesciences community knows it must train, retain & attract more experienced business leaders to grow. @GCMcCauley @adMare_Bio @TIAPToronto @LumiraVentures @OBIOscience @amplitudeVC @ZymeworksInc @Amgen @MaRSDD @globebusiness theglobeandmail.com/business…

Programs target Canada’s chronic biotech talent shortage by training academics to run businesses

Venture capital firms launch new programs to give academics entrepreneurial skills in an effort to help fix the biotech talent gap caused by Canadians moving south of the border

theglobeandmail.com
1
1
Load more